CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- 4 Option exercise Chief Financial Officer acquired 67,452 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 201,632 shares (option exercise)
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Director nominations · Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- RW Other RW
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 74 · 1,465 filings